A detailed history of Alliancebernstein L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 27,277 shares of BIO stock, worth $9.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,277
Previous 23,258 17.28%
Holding current value
$9.06 Million
Previous $6.35 Million 43.69%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $1.06 Million - $1.39 Million
4,019 Added 17.28%
27,277 $9.13 Million
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $432,703 - $547,581
-1,613 Reduced 6.49%
23,258 $6.35 Million
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $127 Million - $147 Million
-416,831 Reduced 94.37%
24,871 $8.6 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $1.87 Million - $2.54 Million
6,949 Added 1.6%
441,702 $143 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $8.56 Million - $10.3 Million
-24,444 Reduced 5.32%
434,753 $156 Million
Q2 2023

Aug 15, 2023

SELL
$359.49 - $486.4 $30.3 Million - $41 Million
-84,373 Reduced 15.52%
459,197 $174 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $26.2 Million - $31.5 Million
62,674 Added 13.03%
543,570 $260 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $18.6 Million - $24.1 Million
-52,869 Reduced 9.9%
480,896 $202 Million
Q3 2022

Nov 15, 2022

SELL
$412.59 - $563.26 $34.1 Million - $46.5 Million
-82,551 Reduced 13.39%
533,765 $223 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $16.9 Million - $21.8 Million
-36,431 Reduced 5.58%
616,316 $305 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $34.8 Million - $48.7 Million
66,258 Added 11.3%
652,747 $368 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $28.4 Million - $31.8 Million
40,012 Added 7.32%
586,489 $443 Million
Q3 2021

Nov 10, 2021

BUY
$657.71 - $825.77 $14.8 Million - $18.6 Million
22,502 Added 4.29%
546,477 $408 Million
Q2 2021

Jul 30, 2021

BUY
$576.64 - $649.04 $33.2 Million - $37.4 Million
57,614 Added 12.35%
523,975 $338 Million
Q1 2021

May 06, 2021

BUY
$547.01 - $662.35 $43.3 Million - $52.4 Million
79,174 Added 20.45%
466,361 $266 Million
Q4 2020

Feb 08, 2021

BUY
$510.68 - $643.45 $12 Million - $15.1 Million
23,539 Added 6.47%
387,187 $226 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $16.9 Million - $20 Million
-37,282 Reduced 9.3%
363,648 $187 Million
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $5.51 Million - $8.11 Million
16,449 Added 4.28%
400,930 $181 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $1.97 Million - $2.51 Million
6,148 Added 1.63%
384,481 $135 Million
Q4 2019

Feb 18, 2020

BUY
$319.73 - $374.2 $3.24 Million - $3.79 Million
10,127 Added 2.75%
378,333 $140 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $1.36 Million - $1.54 Million
4,469 Added 1.23%
368,206 $123 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $900,099 - $980,594
-3,137 Reduced 0.86%
363,737 $114 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $28.2 Million - $40 Million
125,940 Added 52.27%
366,874 $112 Million
Q4 2018

Feb 13, 2019

SELL
$220.1 - $309.0 $5.99 Million - $8.41 Million
-27,204 Reduced 10.15%
240,934 $56 Million
Q3 2018

Nov 08, 2018

BUY
$289.28 - $326.15 $3.09 Million - $3.49 Million
10,691 Added 4.15%
268,138 $83.9 Million
Q2 2018

Aug 13, 2018

SELL
$244.1 - $303.88 $18.2 Million - $22.7 Million
-74,670 Reduced 22.48%
257,447 $74.3 Million
Q1 2018

May 14, 2018

BUY
$233.97 - $274.11 $1.44 Million - $1.69 Million
6,171 Added 1.89%
332,117 $83.1 Million
Q4 2017

Feb 13, 2018

SELL
$216.94 - $271.3 $856,262 - $1.07 Million
-3,947 Reduced 1.2%
325,946 $77.8 Million
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $70 Million - $79.9 Million
329,893
329,893 $73.3 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.